GlassScriptPhysician profile
Vivian C Cook
NPI 1386805307
$2,970.89
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,822 · 2021: $11.92 · 2022: $18.14 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $61.52 · Food and Beverage: $56.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $61.52 |
| Food and Beverage | $56.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $1,918.00 | 2019 | |
| Amgen INC. | $218.66 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $110.74 | 2019-2024 | Enhertu |
| E.R. Squibb & Sons, L.L.C. | $75.43 | 2019 | |
| Janssen Biotech, INC. | $68.90 | 2019-2024 | Darzalex, Tecvayli |
| Exelixis INC. | $56.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.79 | 2019 | |
| Merck Sharp & Dohme LLC | $46.29 | 2019 | |
| Genentech USA, INC. | $42.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.69 | 2019 | |
| Celgene Corporation | $31.27 | 2019 | |
| Genzyme Corporation | $29.50 | 2019 | |
| Emd Serono, INC. | $28.91 | 2019-2022 | |
| Eisai INC. | $27.72 | 2019 | |
| Tesaro, INC. | $27.25 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $27.03 | 2019-2021 | |
| Seagen INC. | $26.47 | 2019 | |
| Aveo Pharmaceuticals, INC. | $20.00 | 2024 | |
| Rigel Pharmaceuticals, INC. | $15.99 | 2019 | |
| Clovis Oncology, INC. | $15.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.21 | 2019 | |
| Lilly USA, LLC | $14.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.63 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $14.24 | 2019 | |
| Astellas Pharma US INC | $14.02 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.17 | 2019 | |
| Pfizer INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.